GO:0060124 positive regulation of growth hormone secretion: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060124 describes any biological process that increases the frequency, rate, or extent of regulated growth hormone (GH) release from a cell.
• GH secretion is controlled by a complex interplay of hypothalamic peptides, peripheral hormones, and metabolic signals, including ghrelin, Klotho, nesfatins, insulin, and the (pro)renin receptor [1,3,4].
• Dysregulation of GH secretion is linked to growth disorders, metabolic disease, and fertility issues [2,5].
• Key genes/proteins involved include GH1, GHRH, GHRL, SST, IGF1, and INSR, among others [1,4].
• CRISPR-based models (knockout, knock-in, overexpression) enable causal dissection of genes that positively regulate GH secretion [3,6].
• Understanding this process informs therapeutic strategies for GH deficiency, acromegaly, and related endocrine disorders [1,5].
Description
Growth hormone (GH) is a pleiotropic pituitary hormone essential for postnatal growth, metabolism, and reproduction [1,5]. Its secretion is tightly controlled by a network of stimulatory and inhibitory signals that converge on somatotroph cells of the anterior pituitary. The Gene Ontology term GO:0060124, positive regulation of growth hormone secretion, captures the processes that enhance the frequency, rate, or extent of GH release. This term is critical for researchers studying endocrine regulation, because perturbations in GH secretion underlie a spectrum of clinical conditions, from short stature to acromegaly and metabolic syndrome [2,5]. Recent studies have expanded the list of regulators beyond classical hypothalamic hormones, implicating ghrelin, Klotho, nesfatins, insulin, and the (pro)renin receptor in modulating GH secretion [1,3,4]. Understanding these positive regulatory mechanisms at the molecular level is essential for developing targeted therapies and for interpreting genetic variants associated with growth disorders [2,5].
positive regulation of growth hormone secretion At A Glance
| GO ID | GO:0060124 |
|---|---|
| GO term | positive regulation of growth hormone secretion |
| Ontology | biological_process |
| Synonym | none |
| Major function | Enhances the regulated release of growth hormone from cells |
| Related processes | Hormone secretion, peptide secretion, regulation of signaling |
| Key cell types | Pituitary somatotrophs, placental trophoblasts, immune cells |
| Major regulators | GHRH, ghrelin, Klotho, nesfatins, insulin, (pro)renin receptor |
What Is GO:0060124?
GO:0060124, positive regulation of growth hormone secretion, is defined as any process that increases the frequency, rate, or extent of the regulated release of growth hormone from a cell. This encompasses signaling events, transcriptional changes, and secretory machinery modifications that ultimately enhance GH exocytosis from somatotrophs or other GH-producing cells.
Why Is positive regulation of growth hormone secretion Important in Cell Biology?
Positive regulation of GH secretion is fundamental to normal growth, metabolism, and reproductive function [1,5]. Its dysregulation contributes to pediatric growth disorders, adult GH deficiency, and acromegaly, and it influences insulin sensitivity, lipid metabolism, and fertility [2,4,5]. Moreover, GH secretion is altered in conditions such as obesity, diabetes, and aging, making this process a key node for therapeutic intervention [1,4].
• Essential for postnatal growth and skeletal development.
• Regulates metabolic homeostasis, including insulin sensitivity and lipid mobilization.
• Impacts fertility and reproductive function.
• Dysregulation leads to growth hormone deficiency or excess (acromegaly).
• Involved in placental development and fetal growth.
• Modulated by nutritional status and adipokines.
• Target for therapies in endocrine and metabolic diseases [1,5].
• Provides a model for studying regulated secretion in neuroendocrine cells.
• Relevant to aging and longevity pathways via Klotho and nesfatins.
• Cross-talk with immune and inflammatory signals.
What Happens During positive regulation of growth hormone secretion?
Hypothalamic Stimulation
In simple terms: The brain sends signals to the pituitary to release growth hormone.
Hypothalamic growth hormone-releasing hormone (GHRH) binds to its receptor on pituitary somatotrophs, activating cAMP-dependent signaling and increasing GH secretion. Ghrelin, produced in the stomach and hypothalamus, also stimulates GH release via the growth hormone secretagogue receptor (GHSR).
Peripheral Hormonal Modulation
In simple terms: Hormones from other organs can boost growth hormone release.
Klotho and nesfatins have been shown to modulate GH secretion, with Klotho enhancing and nesfatin-1 inhibiting GH release in some contexts. Insulin can influence GH secretion and signaling, particularly under metabolic stress.
Intracellular Signaling and Secretory Machinery
In simple terms: Inside the cell, specific pathways prepare and release growth hormone.
The (pro)renin receptor regulates GH secretion by modulating intracellular calcium and cAMP levels. Activation of these pathways leads to exocytosis of GH-containing secretory granules.
Feedback and Integration
In simple terms: The body monitors growth hormone levels and adjusts release accordingly.
IGF-1, produced in response to GH, feeds back to inhibit further GH secretion, while positive regulators like ghrelin can override this feedback under certain conditions [1,4].
Key Genes Involved in GO:0060124 positive regulation of growth hormone secretion
The following genes and proteins are central to the positive regulation of growth hormone secretion, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GH1 | Encodes growth hormone | Mutations cause GH deficiency; target for overexpression/KO studies |
| GHRH | Stimulates GH secretion | Hypothalamic regulator; KO models show reduced GH |
| GHRL | Encodes ghrelin, a GH secretagogue | Positive regulator; KO alters GH pulsatility |
| GHSR | Ghrelin receptor | Mediates ghrelin-stimulated GH release |
| SST | Encodes somatostatin, inhibits GH | Negative regulator; KO increases GH |
| IGF1 | Mediates GH feedback | Negative feedback; KO affects GH secretion |
| INSR | Insulin receptor | Modulates GH secretion and signaling |
| ATP6AP2 | Encodes (pro)renin receptor | Regulates GH secretion via calcium/cAMP |
| KL | Encodes Klotho | Enhances GH secretion in some models |
| NUCB2 | Encodes nesfatin-1 | Modulates GH secretion |
| POU1F1 | Pituitary transcription factor | Essential for somatotroph development |
| PROP1 | Pituitary transcription factor | Mutations cause combined pituitary hormone deficiency |
| GHRHR | GHRH receptor | Mutations cause GH deficiency |
| LEPR | Leptin receptor | Links energy status to GH secretion |
| ADIPOR1 | Adiponectin receptor | Adipokine modulation of GH |
| CSF2 | GM-CSF, placental GH regulation | Modulates placental GH secretion |
| IL6 | Interleukin-6 | Influences GH secretion in inflammation |
| TNF | Tumor necrosis factor | Modulates GH secretion |
How Is positive regulation of growth hormone secretion Regulated?
Positive regulation of GH secretion is controlled by a balance of stimulatory and inhibitory signals. Hypothalamic GHRH and ghrelin stimulate secretion, while somatostatin inhibits it. Peripheral hormones such as insulin, Klotho, and nesfatins modulate the response [1,4]. Intracellularly, cAMP, calcium, and the (pro)renin receptor play key roles. Feedback from IGF-1 provides a long-loop negative regulation. Metabolic status, including glucose and lipid levels, further tunes GH release [4,6].
positive regulation of growth hormone secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GH1 | GH deficiency, short stature | Knockout mice, patient iPSCs |
| GHRHR | GH deficiency | Knock-in of patient mutations |
| GHRL | Metabolic syndrome, obesity | Overexpression/KO models |
| ATP6AP2 | Hypertension, metabolic disorders | Conditional KO in pituitary |
| IGF1 | Growth failure, insulin resistance | Liver-specific KO |
Growth Hormone Deficiency and Short Stature
Impaired positive regulation of GH secretion can lead to GH deficiency, resulting in short stature and metabolic abnormalities. Mutations in GHRH, GHRHR, or GH1 are classic causes.
Acromegaly and Pituitary Adenomas
Excessive GH secretion, often due to pituitary adenomas, causes acromegaly and gigantism. Dysregulated positive signals, such as overactive ghrelin or GHRH pathways, contribute to pathogenesis.
Metabolic Syndrome and Diabetes
Altered GH secretion is associated with insulin resistance, obesity, and diabetes. Insulin modulates GH secretion, and vice versa, creating a complex interplay in metabolic disease.
Fertility and Reproductive Disorders
GH influences fertility through effects on gonadal function. Disrupted GH secretion can contribute to infertility and reproductive disorders.
From positive regulation of growth hormone secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate GH secretion? | CRISPR knockout in GH3 or AtT-20 cells |
| What is the effect of a point mutation in GHRHR? | Knock-in point mutation in iPSCs |
| Can overexpression of ghrelin increase GH secretion? | Lentiviral overexpression in somatotrophs |
| How does Klotho modulate GH secretion? | Tagged knock-in for live imaging |
| What is the role of (pro)renin receptor in GH secretion? | Conditional KO in pituitary |
| Does insulin signaling cross-talk with GH secretion? | Double KO of INSR and GHR |
How to Study the positive regulation of growth hormone secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on GH secretion | Identify positive regulators |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Proteomics | Protein abundance and modifications | Signaling studies |
| Live-cell imaging | Granule trafficking and exocytosis | Real-time secretion |
| ELISA | GH concentration in media | Quantify secretion |
| Patch-clamp | Electrical activity of somatotrophs | Excitability studies |
| ChIP-seq | Transcription factor binding | Regulatory element mapping |
CRISPR Screening
Genome-wide CRISPR screens can identify positive regulators of GH secretion by selecting for cells with increased GH release.
RNA-seq and Transcriptomics
RNA sequencing reveals transcriptional changes in somatotrophs under conditions that enhance GH secretion.
Proteomics and Secretomics
Mass spectrometry-based secretomics can quantify GH and other secreted factors to assess positive regulation.
Live-cell Imaging
Fluorescently tagged GH allows real-time visualization of secretory granule dynamics.
How CRISPR Can Be Used to Study GO:0060124 positive regulation of growth hormone secretion
Knockout
CRISPR knockout of candidate genes in GH-secreting cell lines (e.g., GH3, AtT-20) can determine whether they are required for positive regulation of GH secretion.
Point Mutation
Introducing patient-derived point mutations (e.g., in GHRHR) via CRISPR knock-in allows functional assessment of variants that affect GH secretion.
Knock-in
Tagged knock-in of GH or regulatory proteins enables live-cell imaging and proteomic analysis of the secretory pathway.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can test whether increasing a gene's activity enhances GH secretion.
How EDITGENE Supports positive regulation of growth hormone secretion Research
Researchers studying positive regulation of growth hormone secretion-related genes often need to determine whether a candidate gene is causally involved in enhancing GH release. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of growth hormone secretion research.
Frequently Asked Questions About positive regulation of growth hormone secretion
What is GO:0060124?
GO:0060124 is the Gene Ontology term for positive regulation of growth hormone secretion, describing processes that increase the release of growth hormone from cells.
What genes are involved in positive regulation of growth hormone secretion?
Key genes include GH1, GHRH, GHRL, GHSR, IGF1, INSR, and ATP6AP2, among others [1,3,4].
How is growth hormone secretion regulated?
It is regulated by hypothalamic GHRH and ghrelin (stimulatory), somatostatin (inhibitory), and peripheral hormones like insulin and Klotho [1,4].
What diseases are associated with abnormal growth hormone secretion?
Growth hormone deficiency, acromegaly, metabolic syndrome, and fertility disorders [2,4,5].
What experimental models are used to study positive regulation of GH secretion?
CRISPR knockout/knock-in in cell lines, animal models, and patient-derived iPSCs [3,6].
How can CRISPR help study GH secretion?
CRISPR enables precise gene knockout, knock-in, and overexpression to test causal roles in GH secretion.
What is the role of ghrelin in GH secretion?
Ghrelin stimulates GH release by binding to GHSR on somatotrophs.
Does insulin affect growth hormone secretion?
Yes, insulin modulates GH secretion and signaling, particularly in metabolic contexts.
What is the (pro)renin receptor's role in GH secretion?
It regulates GH secretion by influencing intracellular calcium and cAMP.
How does Klotho influence GH secretion?
Klotho has been shown to enhance GH secretion in some experimental models.
Conclusion
Positive regulation of growth hormone secretion (GO:0060124) is a vital biological process with broad implications for growth, metabolism, and reproduction. Understanding its molecular players and regulatory mechanisms is essential for developing therapies for endocrine disorders. CRISPR-based approaches offer powerful tools to dissect these pathways and identify new therapeutic targets.
References
- 1. Devesa J. 2021. The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It.. Front Endocrinol (Lausanne) 12:636403 PMID: 33776931
- 2. Zachmann M. 1990. Assessment of growth hormone secretion in children.. Keio J Med 39(3):173-86 PMID: 2255128
- 3. Tani Y et al.. 2015. Regulation of growth hormone secretion by (pro)renin receptor.. Sci Rep 5:10878 PMID: 26039928
- 4. Qiu H et al.. 2017. Influence of insulin on growth hormone secretion, level and growth hormone signalling.. Sheng Li Xue Bao 69(5):541-556 PMID: 29063103
- 5. Chang CW et al.. 2022. Growth hormone in fertility and infertility: Mechanisms of action and clinical applications.. Front Endocrinol (Lausanne) 13:1040503 PMID: 36452322
- 6. Zeck W et al.. 2008. Regulation of placental growth hormone secretion in a human trophoblast model--the effects of hormones and adipokines.. Pediatr Res 63(4):353-7 PMID: 18356738
- 7. Martínez-Moreno CG et al.. 2020. Growth hormone (GH) and synaptogenesis.. Vitam Horm 114:91-123 PMID: 32723552
